Jpmorgan Chase & CO Portage Biotech Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$5.16 - $11.95 $12,095 - $28,010	-2,344 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$6.57 - $12.0 $2,825 - $5,160	430 Added 22.47%	2,344 $15,000
Q4 2021 Feb 10, 2022	SELL	$10.73 - $23.74 $7,650 - $16,926	-713 Reduced 27.14%	1,914 $21,000
Q3 2021 Nov 12, 2021	BUY	$13.65 - $22.4 $35,858 - $58,844	2,627 New	2,627 $53,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $79.8M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.